Nagaraju, Ganji Purnachandra

Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: Special focus on resistance mechanisms and metronomic therapies

Natu, J., & Nagaraju, G. P. (2023) · Cancer Letters

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 73

Regulatory T cells: Their role in triple‐negative breast cancer progression and metastasis

Malla, R. R., Vasudevaraju, P., Vempati, R. K., Rakshmitha, M., Merchant, N., & Nagaraju, G. P. (2022) · Cancer

T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

Cited by 66

Nanoparticles guided drug delivery and imaging in gastric cancer

Nagaraju, G. P., Srivani, G., Dariya, B., Chalikonda, G., Farran, B., Behera, S. K., Alam, A., & Kamal, M. A. (2021) · Seminars in Cancer Biology

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranostics

Cited by 62

Erratum to: Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3

Nagaraju, G. P., Park, W., Wen, J., Mahaseth, H., Landry, J., Farris, A. B., Willingham, F., Sullivan, P. S., Proia, D. A., El-Hariry, I., et al. (2013) · Angiogenesis

Angiogenesis and VEGF in CancerCancer, Hypoxia, and Metabolism

Cited by 49

A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI Cancer

Foote, J. B., Mattox, T. E., Keeton, A. B., Chen, X., Smith, F., Berry, K. L., Holmes, T., Wang, J., Huang, C.-H., Ward, A. B., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory)

Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways

Cited by 13